GILD vs TSBK · P/E 18, rev $7.80B vs P/E 11, rev $79.8M
Gilead Sciences Inc (GILD) versus Timberland Bancorp Inc (TSBK) — a side-by-side from cached financials, not a winner call.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US.
Timberland Bancorp Inc (TSBK) is a banks - regional company listed on NASDAQ.
Latest reported GILD revenue for 2026-06-30 was $7.80B. Net income was -$10.50B. Revenue was up 12.1% from 2026-03-31 to 2026-06-30. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Latest reported TSBK revenue for 2026-06-30 was $79.8M. Net income was $23.1M. Revenue was up 50.2% from 2026-03-31 to 2026-06-30. TSBK currently screens at market cap $328.7M and trailing P/E 10.8.
GILD currently screens at market cap $160.15B and trailing P/E 17.5. TSBK currently screens at market cap $328.7M and trailing P/E 10.8.
Not investment advice. Open the GILD and TSBK stock pages for the full models.
Not investment advice.